Cargando…
Potential of antibody–drug conjugates (ADCs) for cancer therapy
The primary purpose of ADCs is to increase the efficacy of anticancer medications by minimizing systemic drug distribution and targeting specific cells. Antibody conjugates (ADCs) have changed the way cancer is treated. However, because only a tiny fraction of patients experienced long-term advantag...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375290/ https://www.ncbi.nlm.nih.gov/pubmed/35964048 http://dx.doi.org/10.1186/s12935-022-02679-8 |